CClinicalTrials.gg
CompletedNCT03286439Updated Sep 25, 2018

Recovery After Medical or Surgical Treatment

An observational study in Cognitive Deficit, sponsored by Zealand University Hospital. Completed at 1 site in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-09-25.

Sponsored by Zealand University Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
101
Ages
18 Years and older
Sex
All
01

Study summary

This study aims to investigate the in-hospital care as well as the cognitive status, quality of life, physical function and risk of anxiety and depression, sleep disorders and drug use in a Danish cohort of both medical and surgical patients with acute critical illness without admittance to ICU (Intensive Care Unit) treatment, at three and twelve months after hospital discharge.

Read the detailed description

A stay at the ICU (intensive Care Unit) is related to life-threatening conditions and often displays a major impact on both physical and mental resources of the patients. Studies show that a great part of ICU patients have impairments of both physical and psychological kinds, some long-lasting. This condition is termed the "post intensive care syndrome" (PICS) and describes a wide range of symptoms as fatigue, depression, anxiety, memory loss along with both cognitive and physical impairments. Rehabilitative efforts are, thus, needed, and it has been suggested that ideally, rehabilitation should begin at the time of admission to the hospital and continue for a long time, possibly years, after the patient has been discharged. Regarding long term cognitive function of the ICU survivors in particular, recent studies have demonstrated severe impairment at the level of light Alzheimer's disease. In all of these studies, the reference group is the normal population, and it is a general problem that the cognitive and physical function of ICU patients before critical illness is unknown. There has recently been a norwegian study that included a reference group of surgical patients undergoing major surgery. The surgical group was older and more severely ill than the ICU group and was found to have a much worse cognitive function. Moreover, the cognitive function of the critically ill patients was not very far from the normal reference population due to selection.

To determine to which degree the impairments can be attributed to ICU-admission, the investigators need to look at a hospitalised and representative, non-ICU population, which is what will be done in the study. The investigators will therefore include patients that have been admitted to surgical or medical department acute without admittance to the ICU and contact these patients 3 and 12 months after admission. Where there will be performed different tests in order to evaluate the the cognitive status, quality of life, physical function and risk of anxiety and depression, sleep disorders and drug use.

02

Conditions studied

  • Cognitive Deficit
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

The study population consists of critically ill patients that have been admitted to surgical or Medical departement.

Inclusion criteria

  • Patients > 18 years of age
  • Admitted to surgical or medical department > 3 days
  • Admitted with one of the following diagnoses:

    • Pneumonia
    • Heart failure
    • Pulmonary embolism
    • Acute myocardial infarction
    • Pyelonephritis
    • Patients undergoing non-elective open or laparoscopic abdominal surgery (not including elective procedures, diseases of the appendix, diseases of the gallbladder, liver, spleen, kidney, pancreas and emergency hernia surgery without bowel resection)

Exclusion criteria

Exclusion Criteria:

  • Permanently incompetent patients not able to consent
  • Not able to speak and understand Danish
  • Discharged from the hospital for terminal care
  • Patients transferred to another hospital during the stay
  • Patients living outside the Region of Zealand
  • Patients admitted under duress or actively psychotic
  • Patients that are blind or severely visually impaired.
04

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
101 participants (actual)
Patient registry
No

Interventions

  • Otherthere will be offered a follow up visit

    The investigators will offer the patients a follow up visit 3 and 12 months after discharge from the hospital.

05

What researchers measure

Primary outcomes

  1. Cognitive function

    Cognitive Function measured by The Repeatable Battery for The Assesment of Neuropsychological Status (RBANS)

    Time frame: 3 months after discharge

Secondary outcomes

  1. Cognitive function after one year

    Cognitive function measured with The Repeatable Battery for the Assessments of Neuropsychological Status (RBANS) evaluation at 12 months after discharge from hospital

    Time frame: 12 months after discharge

  2. Rehabilitation after 3 months

    This will be investigated by filling out a checklist of community support and contact to health care system at 3 month follow up

    Time frame: 3 months after discharge

  3. Self-reported health related quality of life

    This will be investigated by filling out a questionnaire named SF 36, Short Form Health Survey.

    Time frame: 3 months after discharge

  4. Self-reported health related quality of life

    This will be investigated by filling out a questionnaire named SF 36, Short Form Health Survey.

    Time frame: 12 months after discharge

  5. Objective assessment of physical function

    This will be investigated by filling out a checklist called CPAx, The Chelsea Critical Care Physical Assessment Tool.

    Time frame: 3 months after discharge

  6. Objective assessment of physical function

    This will be investigated by filling out a checklist called CPAx, The Chelsea Critical Care Physical Assessment Tool

    Time frame: 12 months after discharge

  7. Mortality

    The mortality of the patients within 90 days after hospital discharge.

    Time frame: 90 days after discharge

  8. Consumption of opioids

    Percentage of patients with a daily consumption of opioids at hospital admission and 90 days after discharge

    Time frame: 90 days after discharge

  9. Consumption of statins days after discharge

    Percentage of patients with a daily consumption of statins at hospital admission and at 90 days after discharge

    Time frame: 90 days after discharge

  10. Consumption of anti-depressants

    Percentage of patients with a daily consumption of anti-depressants at hospital admission and at 90 days after discharge

    Time frame: 90 days after discharge

  11. Sleepiness

    This will be investigated by filling out Epworth Sleepiness Scale

    Time frame: At inclusion

  12. Sleepiness

    This will be investigated by filling out Epworth Sleepiness Scale

    Time frame: 3 months after discharge

  13. Sleepiness

    This will be investigated by filling out Epworth Sleepiness Scale

    Time frame: 12 months after discharge

  14. Insomnia

    This will be investigated by filling out Insomnia Severity Index

    Time frame: At inclusion

  15. Insomnia

    This will be investigated by filling out Insomnia Severity Index

    Time frame: 3 months after discharge

  16. Insomnia

    This will be investigated by filling out Insomnia Severity Index

    Time frame: 12 months after discharge

  17. Sleep Quality

    This will be investigated by filling out Pittsburgh Sleep Quality Index

    Time frame: At inclusion

  18. Sleep Quality

    This will be investigated by filling out Pittsburgh Sleep Quality Index

    Time frame: 3 months after discharge

  19. Sleep Quality

    This will be investigated by filling out Pittsburgh Sleep Quality Index

    Time frame: 12 months after discharge

  20. Information processing speed

    This will be investigated by filling out the Trail Making Test Part A

    Time frame: 3 months after discharge

  21. Information processing speed

    This will be investigated by filling out the Trail Making Test Part A

    Time frame: 12 months after discharge

  22. Executive function

    This will be investigated by filling out the Trail Making Test Part B

    Time frame: 3 months after discharge

  23. Executive function

    This will be investigated by filling out the Trail Making Test Part B

    Time frame: 12 months after discharge

  24. Rehabilitation after 12 months

    This will be investigated by filling out a checklist of Community support and contact to health care system at 3 month follow up

    Time frame: 12 months

  25. Consumption of sleep medication

    Percentage of patients with a daily consumption of sleep medication at hospital admission and 90 days after discharge

    Time frame: At inclusion

  26. Consumption of sleep medication

    Percentage of patients with a daily consumption of sleep medication at hospital admission and 90 days after discharge

    Time frame: 90 days after discharge

  27. Consumption of sleep medication

    Percentage of patients with a daily consumption of sleep medication at hospital admission and 90 days after discharge

    Time frame: 12 months after discharge

06

Study locations

1 site
  • Zealand University Hospital
    Køge, 4600, Denmark
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03286439
Lead sponsor
Zealand University Hospital
Responsible party
Stine Estrup (Principal Investigator, Zealand University Hospital) — Principal investigator
First posted
Sep 18, 2017
Start date
Nov 13, 2017
Primary completion
Jul 6, 2018
Completion
Jul 6, 2018
Last update
Sep 25, 2018

Study contacts

Stine Estrup, MD
principal investigator · Stine Estrup

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion